Skip to main content

Table 2 Success rate and early hypertensive phase frequency in both groups

From: Comparison of 1-year outcomes after Ahmed glaucoma valve implantation with and without Ologen adjuvant

  OAGV group CAGV group p-value
Complete success 4 (50.0%) 1 (8.3%) 0.035a
Qualified success 6 (75.0%) 6 (50.0%) 0.264a
Early hypertensive phase 1 (12.5%) 4 (33.3%) 0.375b
  1. aχ2-test; bFisher’s exact test; OAGV Ologen-augmented Ahmed glaucoma valve implantation, CAGV conventional Ahmed glaucoma valve implantation